Silva O Rafael, Puelma C Felipe, Retamal P Víctor, Rojas Sm Pedro, Cruzat C Claudio, Reyes G Cecilia
Unidad de Enfermedades Respiratorias, Hospital Regional de Talca, Chile.
Rev Med Chil. 2009 Nov;137(11):1474-7. Epub 2010 Jan 13.
Lymphangioleiomyomatosis (LAM) is a rare interstitial lung disease, of unknown etiology, affecting almost exclusively women. Microscopically LAM consists of a diffuse proliferation of smooth muscle cells. LAM can occur without evidence of other diseases (sporadic LAM) or in conjunction with tuberous sclerosis complex (TSC). It presents with progressive breathlessness or with recurrent pneumothorax or chylothorax. We report a 33 year-old woman with a history of recurrent pneumothorax. Computed tomography (CT) scans showed numerous thin-walled cysts throughout the lungs, a characteristic finding in LAM. A pulmonary biopsy was compatible with the diagnosis and HMB-45 monoclonal antibodies were positive. Treatment with Sirolimus was started).
淋巴管平滑肌瘤病(LAM)是一种病因不明的罕见间质性肺疾病,几乎仅影响女性。显微镜下,LAM由平滑肌细胞的弥漫性增生组成。LAM可在无其他疾病证据的情况下发生(散发性LAM),或与结节性硬化症(TSC)合并出现。其表现为进行性呼吸困难或反复气胸或乳糜胸。我们报告一名有反复气胸病史的33岁女性。计算机断层扫描(CT)显示双肺有大量薄壁囊肿,这是LAM的特征性表现。肺活检结果与诊断相符,HMB - 45单克隆抗体呈阳性。开始使用西罗莫司进行治疗。